Sienna Appoints Swiss Distribution Partner

08-Dec-2016 Sienna Cancer Diagnostics Ltd. and Biosystems Switzerland AG have entered an exclusive distribution agreement for the supply of Sienna’s IVD-registered Anti-hTERT Antibody (SCD-A7) throughout Switzerland.

Biosystems Switzerland is headquartered in Muttenz and is one of Switzerland’s leading laboratory equipment distributors. They specialise in equipment and consumables for pathology laboratories, specifically focussed in cytology, immunopathology and histology.

Sienna’s Chief Operating Officer, Matthew Hoskin commented “We are delighted to secure this agreement with such a reputable and successful company. Biosystems has secured significant market share for their clients and has established sales channels, which they will leverage to penetrate the market with the Sienna product.  The agreement also presents Biosystems with a genuine growth opportunity.”


No Very

Captcha Image

Sign up for updates